Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
View All Featured ArticlesHeadline News
Moderna secures US FDA approval for its influenza vaccine mFLUSIVA
Moderna kicks off Phase 1 clinical trial of mRNA-1469, its investigational vaccine targeting Bundibugyo ebolavirus
Allergan Aesthetics confirms US FDA acceptance of supplemental Biologics License Application for BOTOX Cosmetic in masseter muscle prominence
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
The Journey Of Implementing Advanced Process Control In the Pharmaceutical Industry
Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow, Advanced Technology Center of Excellence, Technical Operations, Janssen Pharmaceuticals and Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech
16th March 2020
Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing
Presented by Clive Glover, PhD, Senior Marketing Manager, Cell & Gene Therapy at Pall and Rachel Legmann, PhD, Senior Manager, Process Development Services at Pall
13th November 2018
Single Use Manufacturing within the Bristol-Myers Squibb Manufacturing Network – Preparing for Commercial Production
Presented by Lance Marquardt, Associate Director - Upstream Processing for Hopewell Clinical Manufacturing at Bristol-Myers Squibb and Sara Bell, Senior Marketing Manager for Merck’s single-use product portfolio
17th January 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
